Eden wins the triple and bags £3m
Liverpool, UK-based biologics specialist Eden Biodesign has won three new manufacturing contracts - worth a total of £3m (€3.5m) – from clients in Europe and Asia.
Archives for December 4, 2008
PharmEng cuts cash burn once again
Canadian contract manufacturer PharmEng International has managed to trim down its costs once again, but is still feeling the pain associated with the opening of its new facility in Sydney, Nova Scotia, and posted a loss of over C$8m (€5m).
DSM to make NicOx’ naproxcinod API
Life sciences firm DSM has landed the contract to manufacture supplies of NicOx’ much vaunted anti-inflammatory agent naproxcinod and looks good for the long term deal.
Pharmaterials enters Phase I manufacture
UK-based Pharmaterials is expanding into the manufacture of products for Phase I trials as a result of demand from clients and a successful 2008.
Common confusions on the supply chain
Common misunderstandings in the steps needed to ensure raw materials are free from contaminants were part of a speech at this year’s AAPS.
Cooperative manufacture of biologics; FDA guide
Final guidance on the cooperative manufacture of licensed biologics has been issued by the FDA, which gives companies an outline of how to share responsibilities through the production process.